Literature DB >> 18614380

Pernicious anemia in a patient with Type 1 diabetes mellitus and alopecia areata universalis.

Thrasivoulos G Tzellos1, Dimitrios K Tahmatzidis, Aimilios Lallas, Kiriaki Apostolidou, Dimitrios G Goulis.   

Abstract

A 27-year-old male, who had developed diabetes mellitus type 1 (DMT1) since the age of eighteen and alopecia areata universalis nine months later, attended the outpatient clinics complaining of general fatigue and shortness of breath. A Schilling test was indicative of pernicious anemia. Antigastric parietal cell (AGPA) and anti-intrinsic factor antibodies were positive, confirming diagnosis of pernicious anemia. Thyroid and Addison's disease were excluded. Gastroscopy revealed atrophic gastritis without any evidence of carcinoid tumors. The aim of this case, which, to our knowledge, is the first one to describe a correlation between diabetes mellitus Type 1 (DMT1), pernicious anaemia, and alopecia areata universalis, is to remind the clinician of the increased risk of pernicious anaemia and gastric carcinoids in DMT1 patients. Screening for AGPA followed by serum gastrin and vitamin B(12) levels constitute the most evidence-based diagnostic approach.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18614380     DOI: 10.1016/j.jdiacomp.2008.05.003

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  3 in total

Review 1.  The Role of Micronutrients in Alopecia Areata: A Review.

Authors:  Jordan M Thompson; Mehwish A Mirza; Min Kyung Park; Abrar A Qureshi; Eunyoung Cho
Journal:  Am J Clin Dermatol       Date:  2017-10       Impact factor: 7.403

2.  Cure of alopecia areata after eradication of Helicobacter pylori: a new association?

Authors:  Germán Campuzano-Maya
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

3.  Frequency and associated factors of hair loss among patients with inflammatory bowel disease.

Authors:  Rajesh Shah; Bincy Abraham; Jason Hou; Joseph Sellin
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.